Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
Antonella Napolitano, Sam Miller, Andrew W. Nicholls, et al.
PLoS ONE (2014) Vol. 9, Iss. 7, pp. e100778-e100778
Open Access | Times Cited: 266

Showing 1-25 of 266 citing articles:

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Sofia K. Forslund, Falk Hildebrand, Trine Nielsen, et al.
Nature (2015) Vol. 528, Iss. 7581, pp. 262-266
Open Access | Times Cited: 1862
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Daniel J. Drucker
Cell Metabolism (2018) Vol. 27, Iss. 4, pp. 740-756
Open Access | Times Cited: 1241
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Lulu Sun, Cen Xie, Guang Wang, et al.
Nature Medicine (2018) Vol. 24, Iss. 12, pp. 1919-1929
Open Access | Times Cited: 801
Metformin and the gastrointestinal tract
Laura McCreight, Clifford J. Bailey, Ewan R. Pearson
Diabetologia (2016) Vol. 59, Iss. 3, pp. 426-435
Open Access | Times Cited: 623
Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
Jacobo de la Cuesta‐Zuluaga, Noel T. Mueller, Vanessa Corrales-Agudelo, et al.
Diabetes Care (2016) Vol. 40, Iss. 1, pp. 54-62
Open Access | Times Cited: 586
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
Xu Zhang, Yufeng Zhao, Jia Xu, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 568
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 10, pp. 569-589
Closed Access | Times Cited: 523
Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors
Jacobo de la Cuesta‐Zuluaga, Noel T. Mueller, Rafael Álvarez, et al.
Nutrients (2018) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 427
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Darleen A. Sandoval, David A. D’Alessio
Physiological Reviews (2015) Vol. 95, Iss. 2, pp. 513-548
Closed Access | Times Cited: 414
Gut microbiome and type 2 diabetes: where we are and where to go?
Sapna Sharma, Prabhanshu Tripathi
The Journal of Nutritional Biochemistry (2018) Vol. 63, pp. 101-108
Closed Access | Times Cited: 357
Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 460-476
Open Access | Times Cited: 323
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities
Louise Brunkwall, Marju Orho‐Melander
Diabetologia (2017) Vol. 60, Iss. 6, pp. 943-951
Open Access | Times Cited: 319
Metformin: Mechanisms in Human Obesity and Weight Loss
Armen Yerevanian, Alexander A. Soukas
Current Obesity Reports (2019) Vol. 8, Iss. 2, pp. 156-164
Open Access | Times Cited: 305
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies
John B. Buse, Ralph A. DeFronzo, Julio Rosenstock, et al.
Diabetes Care (2015) Vol. 39, Iss. 2, pp. 198-205
Open Access | Times Cited: 299
Composition Diversity and Abundance of Gut Microbiome in Prediabetes and Type 2 Diabetes
Vallabh O. Shah, Stacey M Lambeth, Trechelle Carson, et al.
Journal of Diabetes and Obesity (2015) Vol. 2, Iss. 2, pp. 108-114
Open Access | Times Cited: 262
Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies
Kequan Zhou
Journal of Functional Foods (2017) Vol. 33, pp. 194-201
Open Access | Times Cited: 259
Repurposing metformin: an old drug with new tricks in its binding pockets
Rosina Pryor, Filipe Cabreiro
Biochemical Journal (2015) Vol. 471, Iss. 3, pp. 307-322
Open Access | Times Cited: 258
Bile acids in glucose metabolism and insulin signalling — mechanisms and research needs
Tiara R. Ahmad, Rebecca A. Haeusler
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 12, pp. 701-712
Open Access | Times Cited: 249
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
Ulrike Hostalek, Michael Gwilt, Steven Hildemann
Drugs (2015) Vol. 75, Iss. 10, pp. 1071-1094
Open Access | Times Cited: 248
Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study
Tanja Dujić, Kaixin Zhou, Louise A. Donnelly, et al.
Diabetes (2014) Vol. 64, Iss. 5, pp. 1786-1793
Open Access | Times Cited: 241
Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications
Quentin Le Bastard, Gabriel A. Al‐Ghalith, Matthieu Grégoire, et al.
Alimentary Pharmacology & Therapeutics (2017) Vol. 47, Iss. 3, pp. 332-345
Open Access | Times Cited: 218
MECHANISMS IN ENDOCRINOLOGY: Gut microbiota in patients with type 2 diabetes mellitus
Kristine H. Allin, Trine Nielsen, Oluf Pedersen
European Journal of Endocrinology (2014) Vol. 172, Iss. 4, pp. R167-R177
Open Access | Times Cited: 210
The gut microbiota: A treasure for human health
Daotong Li, Pan Wang, Pengpu Wang, et al.
Biotechnology Advances (2016) Vol. 34, Iss. 7, pp. 1210-1224
Closed Access | Times Cited: 210
Understanding and overcoming metformin gastrointestinal intolerance
Fabrice Bonnet, André Scheen
Diabetes Obesity and Metabolism (2016) Vol. 19, Iss. 4, pp. 473-481
Closed Access | Times Cited: 205
Metformin and Autoimmunity: A “New Deal” of an Old Drug
Francesco Ursini, Emilio Russo, Gianluca Pellino, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 181
Page 1 - Next Page

Scroll to top